Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-27

FDA Approved: ASTEPRO ALLERGY — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for ASTEPRO ALLERGY (azelastine hydrochloride) from Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASTEPRO ALLERGY (Azelastine hydrochloride)

Snippet

SUPPL AP for ASTEPRO ALLERGY (AZELASTINE HCL)